🇺🇸 IV azithromycin in United States

8 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 8

Most-reported reactions

1. Injection Site Induration — 1 report (12.5%)
2. Injection Site Pain — 1 report (12.5%)
3. Medication Error — 1 report (12.5%)
4. Monoplegia — 1 report (12.5%)
5. Nausea — 1 report (12.5%)
6. Oedema Peripheral — 1 report (12.5%)
7. Sinus Bradycardia — 1 report (12.5%)
8. Vomiting — 1 report (12.5%)

Source database →

Frequently asked questions

Is IV azithromycin approved in United States?

IV azithromycin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for IV azithromycin in United States?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.